KEGG: sas:SAS0411
The UPF0753 protein SAS0411 belongs to a family of proteins with unknown function (UPF) that are conserved across various Staphylococcus strains. Similar to the characterized SaurJH9_0475 protein, it contains specific structural motifs that may be involved in cellular regulatory functions. While the precise three-dimensional structure hasn't been fully elucidated, it shares sequence homology with proteins involved in phosphate metabolism and regulation .
Recombinant SAS0411 protein is typically produced using E. coli expression systems, similar to other S. aureus recombinant proteins. The gene encoding SAS0411 is cloned into an expression vector, transformed into E. coli, and protein production is induced under controlled conditions. The protein is subsequently purified using affinity chromatography techniques, with recommended purity levels of >85% as determined by SDS-PAGE analysis . For optimal experimental reliability, protein preparations should undergo quality control testing for endotoxin levels and confirmation of protein identity by mass spectrometry.
Recombinant SAS0411 protein stability is dependent on proper storage conditions. Based on similar proteins like SaurJH9_0475, the shelf life of liquid preparations is approximately 6 months at -20°C/-80°C, while lyophilized forms can remain stable for up to 12 months at the same temperatures . To prevent protein degradation, repeated freeze-thaw cycles should be avoided. For short-term use, working aliquots can be stored at 4°C for up to one week . The addition of 5-50% glycerol (with 50% being standard) is recommended for long-term storage to prevent freeze-thaw damage.
For optimal reconstitution of lyophilized SAS0411 protein, begin by briefly centrifuging the vial to ensure the protein powder is at the bottom. Reconstitute in deionized sterile water to achieve a final concentration of 0.1-1.0 mg/mL . For long-term storage, add glycerol to a final concentration of 5-50% (with 50% being standard practice) and aliquot before storing at -20°C/-80°C . When preparing working solutions, consider the buffer compatibility with your downstream applications, as some buffers may interfere with protein activity or experimental outcomes.
Validating the functionality of recombinant SAS0411 requires multiple complementary approaches:
Biochemical assays: Test for specific enzymatic activity if known or predicted based on sequence homology
Binding assays: Evaluate interactions with predicted binding partners using techniques such as pull-down assays, co-immunoprecipitation, or surface plasmon resonance
Structural analysis: Circular dichroism spectroscopy to confirm proper folding
Functional complementation: Express the protein in S. aureus mutants lacking the native gene to assess functional rescue
Comparative analysis with related proteins: Compare activity to better-characterized PhoU homologs to identify functional similarities
These validation steps ensure that the recombinant protein retains biological activity comparable to the native protein.
Several analytical techniques can be employed to study SAS0411 protein interactions:
Co-immunoprecipitation (Co-IP): To identify protein-protein interactions in cellular contexts
Pull-down assays: For in vitro confirmation of direct protein interactions
Surface Plasmon Resonance (SPR): To determine binding kinetics and affinity constants
Isothermal Titration Calorimetry (ITC): For thermodynamic characterization of binding interactions
Proximity labeling techniques: Such as BioID or APEX to identify proximal proteins in cellular environments
Crosslinking Mass Spectrometry (XL-MS): To map interaction interfaces at the amino acid level
When designing interaction studies, researchers should consider that S. aureus proteins often function in complexes, as seen with PhoU homologs that interact with various regulatory and metabolic proteins .
While the specific function of SAS0411 remains to be fully characterized, insights can be drawn from related S. aureus proteins. S. aureus PhoU homologs have been demonstrated to regulate persister formation and virulence factor expression . Deletion of similar regulatory proteins (PhoU1 and PhoU2) resulted in decreased persister formation with vancomycin and levofloxacin by at least 1,000-fold and reduced bacterial survival in A549 cells . If SAS0411 shares functional similarities with these regulatory proteins, it may influence:
Antibiotic tolerance mechanisms
Expression of virulence genes
Metabolic adaptation during infection
Host-pathogen interactions
Research investigating these potential roles would require genetic manipulation approaches such as gene deletion or overexpression followed by phenotypic characterization.
To investigate SAS0411's role in S. aureus metabolism, researchers should employ a multi-faceted approach:
Gene deletion and complementation studies: Generate ΔSAS0411 mutants and complemented strains using temperature-sensitive plasmids (such as pKOR1) and allelic exchange methodologies
Transcriptomic analysis: Compare gene expression profiles between wild-type and mutant strains using RNA-Seq to identify dysregulated metabolic pathways
Metabolomic profiling: Measure intracellular metabolite levels, particularly focusing on key metabolites like ATP, pyruvate, and phosphate-containing compounds
Flux analysis: Employ isotope-labeled substrates to track metabolic flux through central carbon metabolism pathways
Phenotypic microarrays: Assess growth under various nutrient conditions to identify specific metabolic dependencies
Based on studies of related proteins, particular attention should be given to phosphate metabolism and carbon utilization pathways, as these have been implicated in the function of similar regulatory proteins in S. aureus .
While specific information about SAS0411's role in phosphate metabolism is limited in the available search results, insights can be drawn from studies of related proteins. PhoU homologs in S. aureus regulate phosphate metabolism, with PhoU2 specifically involved in inorganic phosphate transport gene regulation . Deletion of PhoU2 resulted in up-regulation of inorganic phosphate transport genes and increased levels of intracellular inorganic polyphosphate .
If SAS0411 shares functional similarities with these regulatory proteins, it may participate in:
Sensing intracellular phosphate levels
Regulating phosphate transport systems
Controlling polyphosphate accumulation
Coordinating phosphate metabolism with other cellular processes
Experimental approaches to investigate this would include measuring intracellular phosphate levels, phosphate uptake rates, and expression of phosphate transport genes in wild-type versus SAS0411 mutant strains.
Designing effective genetic manipulation experiments for studying SAS0411 requires careful planning:
Mutagenesis strategy:
Verification methodology:
Complementation approach:
Express wild-type SAS0411 from a plasmid in the deletion mutant
Use inducible promoters to control expression levels
Include epitope tags for protein detection without interfering with function
Phenotypic characterization:
Assess growth in various media and stress conditions
Measure antibiotic susceptibility and persister formation
Evaluate virulence in cell culture and animal models
Differentiating the specific functions of UPF0753 family proteins from related regulatory proteins presents several challenges:
Functional redundancy: S. aureus contains multiple regulatory proteins with overlapping functions, as seen with PhoU1 and PhoU2, which both affect persister formation but regulate different aspects of metabolism
Context-dependent activity: Protein function may vary depending on growth phase, nutrient availability, and stress conditions
Strain-specific differences: Regulatory networks can differ between S. aureus strains, complicating comparisons across studies
Pleiotropic effects: Deletion of regulatory proteins often affects multiple pathways, making it difficult to identify direct versus indirect effects
Technical limitations: Limited availability of specific antibodies and structural information for UPF0753 family proteins
To address these challenges, researchers should employ complementary approaches including:
Double and triple mutant analysis to address redundancy
Conditional expression systems to control timing and level of expression
Domain-specific mutations to separate different functional aspects
Systems biology approaches to map regulatory networks
Based on studies of related proteins, SAS0411 may interact with multiple regulatory systems controlling S. aureus virulence:
Global regulators: Similar regulatory proteins have been shown to affect expression of global regulators such as SarA, Rot, and CodY, which control numerous virulence factors
Two-component signaling systems: Potential interactions with systems like SaeS/SaeR, which regulate virulence gene expression
Metabolic regulators: Integration with metabolic control systems, particularly those involved in carbon metabolism and energy production
Stress response pathways: Coordination with stress response regulators to adapt virulence expression under different environmental conditions
To investigate these interactions, researchers should conduct:
Epistasis analysis using double mutants
Protein-protein interaction studies using co-immunoprecipitation or bacterial two-hybrid systems
Chromatin immunoprecipitation to identify potential DNA binding sites if SAS0411 functions as a transcription factor
Transcriptomic analysis to identify co-regulated genes under various conditions
For structural studies requiring high-purity SAS0411 protein, the following purification strategy is recommended:
Expression optimization:
Test multiple E. coli strains (BL21(DE3), Rosetta, Arctic Express)
Optimize induction conditions (temperature, IPTG concentration, duration)
Consider fusion tags that enhance solubility (MBP, SUMO, TRX)
Multi-step purification protocol:
Initial capture: Affinity chromatography using His-tag or GST-tag
Intermediate purification: Ion exchange chromatography
Polishing step: Size exclusion chromatography for homogeneity
Tag removal: Site-specific protease cleavage followed by reverse affinity chromatography
Quality control assessments:
SDS-PAGE with Coomassie staining (target >95% purity)
Western blot analysis for identity confirmation
Dynamic light scattering for monodispersity
Mass spectrometry for accurate molecular weight and purity assessment
Buffer optimization:
Screen multiple buffer conditions using differential scanning fluorimetry
Test stabilizing additives (glycerol, specific ions, reducing agents)
Assess long-term stability in various storage conditions
For crystallography studies, additional screening for conditions that promote crystal formation would be necessary.
Designing effective antibodies against SAS0411 requires a strategic approach:
Antigen selection:
Full-length protein: Provides comprehensive epitope coverage but may have specificity issues
Unique peptide regions: Higher specificity but potentially lower sensitivity
Specific structural domains: Balance between specificity and sensitivity
Antibody production strategies:
Polyclonal antibodies: Broader epitope recognition, useful for initial studies
Monoclonal antibodies: Higher specificity, better for distinguishing between related proteins
Recombinant antibodies: Consistent production and potential for engineering enhanced properties
Validation methods:
Western blot analysis using recombinant protein and cellular extracts
Immunoprecipitation efficiency testing
Testing in knockout strains as negative controls
Cross-reactivity assessment with related S. aureus proteins
Application-specific considerations:
For immunofluorescence: Test fixation conditions that preserve epitope accessibility
For immunoprecipitation: Evaluate antibody binding under native conditions
For ELISA: Determine optimal coating and detection conditions
Custom antibody production typically requires 2-4 months and should include comprehensive validation to ensure specificity and sensitivity for SAS0411.
Studying the subcellular localization of SAS0411 in S. aureus requires specialized approaches due to the small cell size and thick peptidoglycan layer:
Fluorescent protein fusion approaches:
C-terminal and N-terminal GFP or mCherry fusions
Verification that fusion proteins retain functionality
Optimization of expression levels to prevent artifacts
Super-resolution microscopy for detailed localization patterns
Immunolocalization methods:
Development of highly specific antibodies against SAS0411
Optimization of fixation and permeabilization for S. aureus
Use of appropriate controls (deletion mutants)
Dual labeling with markers for specific subcellular compartments
Biochemical fractionation:
Separation of membrane, cytoplasmic, and cell wall fractions
Western blot analysis of fractions to detect SAS0411
Comparison with known markers of each fraction
Assessment under different growth conditions or stresses
Proximity labeling approaches:
APEX2 or BioID fusion proteins to identify proximal proteins
Mapping of the local interactome to infer localization
Validation using orthogonal approaches
Based on related proteins like PhoU homologs, researchers should particularly investigate potential membrane association and cytoplasmic distribution patterns that may change under different physiological conditions .
Comparative analysis of SAS0411 with homologous proteins in other Staphylococcus species provides valuable insights into its potential function:
Sequence conservation analysis:
Core domains likely represent functionally critical regions
Variable regions may indicate species-specific adaptations
Conserved motifs suggest shared biochemical activities
Functional differences between species:
Structural comparison approaches:
Homology modeling based on crystal structures from related proteins
Identification of conserved functional domains
Prediction of potential interaction interfaces
Evolutionary rate analysis:
Fast-evolving regions may indicate adaptive functions
Highly conserved regions likely represent core functional domains
This comparative approach can guide the design of functional studies by highlighting the most promising regions for mutagenesis and chimeric protein construction.
The relationship between SAS0411 and bacterial stress response mechanisms can be inferred from studies of related proteins:
Potential role in antibiotic tolerance:
Metabolic stress adaptation:
Nutrient limitation responses:
Integration with global stress regulators:
Potential interactions with stress-responsive transcription factors
Coordination with stringent response mechanisms
Research approaches should include phenotypic characterization of SAS0411 mutants under various stress conditions (oxidative, osmotic, acid, antibiotic stress) and transcriptomic analysis to identify SAS0411-regulated genes during stress exposure.
Several complementary approaches can be employed to elucidate the three-dimensional structure of SAS0411:
Each approach has strengths and limitations, and the optimal strategy may involve a combination of methods tailored to the specific properties of SAS0411.
Systems biology approaches offer powerful tools for understanding SAS0411 within S. aureus regulatory networks:
Multi-omics integration:
Combine transcriptomics, proteomics, and metabolomics data
Identify direct and indirect effects of SAS0411 deletion
Map the regulatory network through correlation analysis
Network modeling and analysis:
Construct gene regulatory networks including SAS0411
Identify network motifs and regulatory hubs
Predict system-wide effects of perturbations
Temporal dynamics studies:
Track regulatory changes across growth phases
Capture acute responses to environmental perturbations
Model time-dependent interactions
In silico prediction and validation:
Generate testable hypotheses about SAS0411 function
Design targeted experimental validation
Iteratively refine models with new experimental data
Studies of related proteins have shown that deletion of PhoU homologs affects multiple regulatory systems, including global regulators (SarA, Rot) and two-component systems (SaeS) , suggesting that SAS0411 may similarly engage in complex regulatory interactions that are best understood through systems approaches.
Understanding SAS0411 function could lead to several important applications:
Novel antimicrobial targets:
Diagnostic applications:
Development of biomarkers for antibiotic-tolerant S. aureus infections
Identification of expression signatures predictive of treatment outcomes
Detection methods for specific strains with altered SAS0411 activity
Vaccine development:
Assessment of SAS0411 as a potential vaccine antigen
Use of attenuated strains with modified SAS0411 as live vaccines
Design of combination vaccine strategies targeting multiple virulence regulators
Biotechnology applications:
Engineering S. aureus strains with modified SAS0411 for research tools
Development of biosensors based on SAS0411 regulatory mechanisms
Utilization in synthetic biology applications